The IL-23/IL-17 axis in psoriatic arthritis

Erika Suzuki, Elizabeth D. Mellins, M. Eric Gershwin, Frank O. Nestle, Iannis Adamopoulos

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Psoriatic arthritis (PsA) is an immune-mediated chronic inflammatory disease, affecting both the skin and joints. Disease progression is associated with aberrant cytokine expression, and TNF blockade is the most successful therapy to date. However, not all patients are responsive to anti-TNF treatment, highlighting the need to better understand the cellular and molecular mechanisms that govern the disease. PsA associations with single nucleotide polymorphisms in IL23R as well as TRAF3IP2 (Act1), a molecule downstream of the IL-17 receptor (IL-17R), have linked the IL-23/IL-17 axis to disease pathology. Although both cytokines are implicated in PsA, a full picture of their cellular targets and pathogenic mechanisms has not yet emerged. In this review, we focus on the IL-23/IL-17 axis-elicited responses mediated by osteoclasts, keratinocytes and neutrophils. Expanding our understanding of the cellular and molecular mechanisms that dictate pathogenicity in PsA will contribute to developing novel treatment strategies to combat disease.

Original languageEnglish (US)
Pages (from-to)496-502
Number of pages7
JournalAutoimmunity Reviews
Volume13
Issue number4-5
DOIs
StatePublished - 2014

Fingerprint

Interleukin-23
Psoriatic Arthritis
Interleukin-17
Interleukin-17 Receptors
Cytokines
Osteoclasts
Keratinocytes
Single Nucleotide Polymorphism
Virulence
Disease Progression
Neutrophils
Chronic Disease
Therapeutics
Joints
Pathology
Skin

Keywords

  • IL-17
  • IL-23
  • NF-κB
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The IL-23/IL-17 axis in psoriatic arthritis. / Suzuki, Erika; Mellins, Elizabeth D.; Gershwin, M. Eric; Nestle, Frank O.; Adamopoulos, Iannis.

In: Autoimmunity Reviews, Vol. 13, No. 4-5, 2014, p. 496-502.

Research output: Contribution to journalArticle

Suzuki, Erika ; Mellins, Elizabeth D. ; Gershwin, M. Eric ; Nestle, Frank O. ; Adamopoulos, Iannis. / The IL-23/IL-17 axis in psoriatic arthritis. In: Autoimmunity Reviews. 2014 ; Vol. 13, No. 4-5. pp. 496-502.
@article{86600f0888f2408981398fa1e382551c,
title = "The IL-23/IL-17 axis in psoriatic arthritis",
abstract = "Psoriatic arthritis (PsA) is an immune-mediated chronic inflammatory disease, affecting both the skin and joints. Disease progression is associated with aberrant cytokine expression, and TNF blockade is the most successful therapy to date. However, not all patients are responsive to anti-TNF treatment, highlighting the need to better understand the cellular and molecular mechanisms that govern the disease. PsA associations with single nucleotide polymorphisms in IL23R as well as TRAF3IP2 (Act1), a molecule downstream of the IL-17 receptor (IL-17R), have linked the IL-23/IL-17 axis to disease pathology. Although both cytokines are implicated in PsA, a full picture of their cellular targets and pathogenic mechanisms has not yet emerged. In this review, we focus on the IL-23/IL-17 axis-elicited responses mediated by osteoclasts, keratinocytes and neutrophils. Expanding our understanding of the cellular and molecular mechanisms that dictate pathogenicity in PsA will contribute to developing novel treatment strategies to combat disease.",
keywords = "IL-17, IL-23, NF-κB, Psoriatic arthritis",
author = "Erika Suzuki and Mellins, {Elizabeth D.} and Gershwin, {M. Eric} and Nestle, {Frank O.} and Iannis Adamopoulos",
year = "2014",
doi = "10.1016/j.autrev.2014.01.050",
language = "English (US)",
volume = "13",
pages = "496--502",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "4-5",

}

TY - JOUR

T1 - The IL-23/IL-17 axis in psoriatic arthritis

AU - Suzuki, Erika

AU - Mellins, Elizabeth D.

AU - Gershwin, M. Eric

AU - Nestle, Frank O.

AU - Adamopoulos, Iannis

PY - 2014

Y1 - 2014

N2 - Psoriatic arthritis (PsA) is an immune-mediated chronic inflammatory disease, affecting both the skin and joints. Disease progression is associated with aberrant cytokine expression, and TNF blockade is the most successful therapy to date. However, not all patients are responsive to anti-TNF treatment, highlighting the need to better understand the cellular and molecular mechanisms that govern the disease. PsA associations with single nucleotide polymorphisms in IL23R as well as TRAF3IP2 (Act1), a molecule downstream of the IL-17 receptor (IL-17R), have linked the IL-23/IL-17 axis to disease pathology. Although both cytokines are implicated in PsA, a full picture of their cellular targets and pathogenic mechanisms has not yet emerged. In this review, we focus on the IL-23/IL-17 axis-elicited responses mediated by osteoclasts, keratinocytes and neutrophils. Expanding our understanding of the cellular and molecular mechanisms that dictate pathogenicity in PsA will contribute to developing novel treatment strategies to combat disease.

AB - Psoriatic arthritis (PsA) is an immune-mediated chronic inflammatory disease, affecting both the skin and joints. Disease progression is associated with aberrant cytokine expression, and TNF blockade is the most successful therapy to date. However, not all patients are responsive to anti-TNF treatment, highlighting the need to better understand the cellular and molecular mechanisms that govern the disease. PsA associations with single nucleotide polymorphisms in IL23R as well as TRAF3IP2 (Act1), a molecule downstream of the IL-17 receptor (IL-17R), have linked the IL-23/IL-17 axis to disease pathology. Although both cytokines are implicated in PsA, a full picture of their cellular targets and pathogenic mechanisms has not yet emerged. In this review, we focus on the IL-23/IL-17 axis-elicited responses mediated by osteoclasts, keratinocytes and neutrophils. Expanding our understanding of the cellular and molecular mechanisms that dictate pathogenicity in PsA will contribute to developing novel treatment strategies to combat disease.

KW - IL-17

KW - IL-23

KW - NF-κB

KW - Psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=84896313565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896313565&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2014.01.050

DO - 10.1016/j.autrev.2014.01.050

M3 - Article

C2 - 24424175

AN - SCOPUS:84896313565

VL - 13

SP - 496

EP - 502

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 4-5

ER -